Mutational analysis of primary and metastatic colorectal cancer samples underlying the resistance to cetuximab-based therapy

類似資料

• MicroRNA expression profiling identifies miR-31-5p/3p as associated with time to progression in wild-type RAS metastatic colorectal cancer treated with cetuximab
  著者:: Mlcochova, Jitka, 等
  出版事項: (2015)
• P-010 Next generation sequencing mutational analysis of primary and metastatic colorectal cancer samples in relationship to efficacy of cetuximab-based therapy
  著者:: Nemecek, R., 等
  出版事項: (2016)
• Prediction of response to anti-EGFR antibody-based therapies by multigene sequencing in colorectal cancer patients
  著者:: Lupini, Laura, 等
  出版事項: (2015)
• Long non-coding RNA ZFAS1 interacts with CDK1 and is involved in p53-dependent cell cycle control and apoptosis in colorectal cancer
  著者:: Thorenoor, Nithyananda, 等
  出版事項: (2015)
• Identification and functional screening of microRNAs highly deregulated in colorectal cancer
  著者:: Faltejskova, Petra, 等
  出版事項: (2012)